Public hearing - scheduling of drugs in Schedule I

Project 8757 - Final 
Board of Pharmacy 
September 2026 scheduling of chemicals in Schedule I 
18VAC110-20-322. Placement of chemicals in Schedule I.  
A. Pursuant to subsection D of § 54.1 -3443 of the Code of Virginia, the Board of Pharmacy 
places the following in Schedule I of the Drug Control Act: 
1. Compound expected to have depressant properties. 7 -Bromo-5-(2-chlorophenyl)-1,3-
dihydro-2H-1,4-benzodiazepin-2-one (other name: phenazepam), its salts, isomers, and 
salts of isomers whenever the existence of such salts, isomers, and salts of isomers is 
possible within the specific chemical designation. 
2. Cannabimimetic agent. Methyl N -[(5-methyl-1H-indazol-3-yl)carbonyl]-3-methyl-
valinate (other name: MDMB -5Me-INACA), its salts, isomers, and salts of isomers 
whenever the existence of such salts, isomers, and salts of isomers is possible within the 
specific chemical designation. 
The placement of drugs listed in this subsection shall remain in effect until November 21, 
2026, unless enacted into law in the Drug Control Act. 
B. Pursuant to subsection D of § 54.1 -3443 of the Code of Virginia, the Board of Pharmacy 
places the following in Schedule I of the Drug Control Act: 
1. The following compounds classified as synthetic opioids: 
a. 2 -[(4-methoxyphenyl)methyl]-5-nitro-1-(2-pyrrolidin-1-ylethyl)benzimidazole (other 
names: metonitazepyne, N -pyrrolidino metonitazene), its isomers, esters, ethers, 
salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever 
the existence of these isomers, esters, ethers, and salts is possible within the specific 
chemical designation. 
b. 2 -[2-[(4-ethoxyphenyl)methyl]-5-nitrobenzimidazol-1-yl]-N-ethylethanamine (other 
name: N-desethyl etonitazene), its isomers, esters, ethers, salts, and salts of isomers, 
esters, and ethers, unless specifically excepted, whenever the existence of these 
isomers, esters, ethers, and salts is possible within the specific chemical designation. 
c. N -(2-methylphenyl)-N-[1-(2-phenethyl)piperidin-4-yl]propanamide (other name: 
ortho-methylfentanyl), its isomers, esters, ethers, salts, and salts of isomers, esters, 
and ethers, unless specifically excepted, whenever the existence of these isomers, 
esters, ethers, and salts is possible within the specific chemical designation. 
2. The following compounds expected to have hallucinogenic properties: 
a. [3 -[2-(diethylamino)ethyl]-1H-indol-4-yl] acetate (other names: 4 -acetoxy-N,N-
diethyltryptamine; 4-acetoxy DET; 4-AcO-DET; ethacetin), its salts, isomers, and salts 
of isomers whenever the existence of such salts, isomers, and salts of isomers is 
possible within the specific chemical designation. 
b. 3 -[2-(diethylamino)ethyl]-1H-indol-4-ol (other names: 4 -hydroxy-N,N-
diethyltryptamine; 4-hydroxy DET; ethocin), its salts, isomers, and salts of isomers 
whenever the existence of such salts, isomers, and salts of isomers is possible within 
the specific chemical designation. 
c. 3-methylmethcathinone (other names: 3-MMC; metaphedrone; 2-(methylamino)-1-
(3-methylphenyl)propan-1-one), its salts, isomers, and salts of isomers whenever the 
existence of such salts, isomers, and salts of isomers is possible within the specific 
chemical designation. 
3. The following compounds classified as cannabimimetic agents: 
a. N -(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1H-indazole-3-carboxamide (other 
name: ADB-INACA), its salts, isomers, and salts of isomers whenever the existence 
of such salts, isomers, and salts of isomers is possible within the specific chemical 
designation. 
b. N-cyclohexyl-2-(1-pentylindol-3-yl)acetamide (other names: cyclohexyl-PIATA, CH-
PIACA, CH-PIATA), its salts, isomers, and salts of isomers whenever the existence of 
such salts, isomers, and salts of isomers is possible within the specific chemical 
designation. 
The placement of drugs listed in this subsection shall remain in effect until November 21, 
2026, unless enacted into law in the Drug Cont